Hans-Georg Rammensee took up his studies of biology at the Eberhard Karls University in Tübingen in 1974. In 1982 he completed his PhD at the Max Planck Institute for Biology in Tübingen in the group of Professor Dr. Jan Klein. Following his postdoctoral studies at the Scripps Institute in La Jolla and at the Basel Institute of Immunology, he again joined the Max Planck Institute for Biology where he was group leader of the laboratory of immunology from 1987 to 1993. During this time, he also assumed teaching responsibilities at the University of Tübingen.
From 1993 to 1996 he was Head of the Department of Tumor-Virus Immunology at the German Cancer Research Center (DKFZ), and was also professor at the University of Heidelberg.
From 1996 to 2023 he was Head of the Department of Immunology at the University of Tübingen and professor at the University of Tübingen. He was chair of the SFB 685 (Collaborative Research Centre) from 2005 until 2017, and deputy site coordinator of the German Consortium for Translational Cancer Research (DKTK), and co-chair of the Excellence Cluster 2180, iFIT. Now he is senior professor at the Institute of Immunology. Professor Rammensee is author of more than 400 articles, many of which have been published in top international journals including Nature, Cell and Science. For many years he has also been co-editor of several journals including Immunogenetics, Cellular and Molecular Life Science, European Journal of Immunology and others.
Professor Rammensee’s work on MHC molecules and associated peptides is perceived to be a milestone in the history of immunology. Currently, he is dedicated to furthering the development of individualized cancer immunotherapy.